Though recent reports link SARS-CoV-2 infections with hyper-inflammatory states in
children, most children experience no/mild symptoms, and hospitalization and mortality rates …

Objective: The prognosis of mild and severe patients has prominent differences during the
prevalence of COVID-19, and it will be significant to identify patients' potential risk of …

Interstitial lung disease and associated fibrosis occur in a proportion of individuals who have
recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Background In pandemic COVID-19 (coronavirus disease 2019), the prognosis of patients
has been determined using clinical data and CT (computed tomography) scans, but it is still …

Despite the growing knowledge of the clinicopathological features of COVID-19, the
correlation between early changes in the laboratory parameters and the clinical outcomes of …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a
rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than …

Introduction COVID-19 is severely affecting countries globally and mortality is high.
Xuebijing (XBJ) injection is widely used in the treatment of severe pneumonia and sepsis in …

Coughing is a dynamic physiological process resulting from input of vagal sensory neurons
innervating the airways and perceived airway irritation. Although cough serves to protect …

Background COVID-19 causes fatal cardiac damages. Despite many overwhelming meta-
analysis related to cardiac complications following COVID-19 disease, no umbrella meta …

Convalescent plasma can provide passive immunity during viral outbreaks, but the benefit is
uncertain for the treatment of novel coronavirus disease 2019 (COVID‐19). Our goal is to …